129 related articles for article (PubMed ID: 37259564)
1. The FGFR inhibitor PD173074 binds to the C-terminus of oncofetal HMGA2 and modulates its DNA-binding and transcriptional activation functions.
Ahmed SM; Ragunathan P; Shin J; Peter S; Kleissle S; Neuenschwander M; Schäfer R; Kries JPV; Grüber G; Dröge P
FEBS Lett; 2023 Aug; 597(15):1977-1988. PubMed ID: 37259564
[TBL] [Abstract][Full Text] [Related]
2. Cell-based high-throughput compound screening reveals functional interaction between oncofetal HMGA2 and topoisomerase I.
Peter S; Yu H; Ivanyi-Nagy R; Dröge P
Nucleic Acids Res; 2016 Dec; 44(22):e162. PubMed ID: 27587582
[TBL] [Abstract][Full Text] [Related]
3. Oncofetal HMGA2 effectively curbs unconstrained (+) and (-) DNA supercoiling.
Zhao X; Peter S; Dröge P; Yan J
Sci Rep; 2017 Aug; 7(1):8440. PubMed ID: 28814752
[TBL] [Abstract][Full Text] [Related]
4. The chromatin structuring protein HMGA2 influences human subtelomere stability and cancer chemosensitivity.
Ahmed SM; Ramani PD; Wong SQR; Zhao X; Ivanyi-Nagy R; Leong TC; Chua C; Li Z; Hentze H; Tan IB; Yan J; DasGupta R; Dröge P
PLoS One; 2019; 14(5):e0215696. PubMed ID: 31067275
[TBL] [Abstract][Full Text] [Related]
5. The high mobility group protein HMGA2: a co-regulator of chromatin structure and pluripotency in stem cells?
Pfannkuche K; Summer H; Li O; Hescheler J; Dröge P
Stem Cell Rev Rep; 2009 Sep; 5(3):224-30. PubMed ID: 19551524
[TBL] [Abstract][Full Text] [Related]
6. Energetics of binding the mammalian high mobility group protein HMGA2 to poly(dA-dT)2 and poly(dA)-poly(dT).
Cui T; Wei S; Brew K; Leng F
J Mol Biol; 2005 Sep; 352(3):629-45. PubMed ID: 16109425
[TBL] [Abstract][Full Text] [Related]
7. HMGA2 regulates transcription of the Imp2 gene via an intronic regulatory element in cooperation with nuclear factor-kappaB.
Cleynen I; Brants JR; Peeters K; Deckers R; Debiec-Rychter M; Sciot R; Van de Ven WJ; Petit MM
Mol Cancer Res; 2007 Apr; 5(4):363-72. PubMed ID: 17426251
[TBL] [Abstract][Full Text] [Related]
8. The Mammalian High Mobility Group Protein AT-Hook 2 (HMGA2): Biochemical and Biophysical Properties, and Its Association with Adipogenesis.
Su L; Deng Z; Leng F
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32466162
[TBL] [Abstract][Full Text] [Related]
9. Nanoscale Assembly of High-Mobility Group AT-Hook 2 Protein with DNA Replication Fork.
Krahn N; Meier M; To V; Booy EP; McEleney K; O'Neil JD; McKenna SA; Patel TR; Stetefeld J
Biophys J; 2017 Dec; 113(12):2609-2620. PubMed ID: 29262356
[TBL] [Abstract][Full Text] [Related]
10. Oncofetal HMGA2 attenuates genotoxic damage induced by topoisomerase II target compounds through the regulation of local DNA topology.
Ahmed SM; Dröge P
Mol Oncol; 2019 Oct; 13(10):2062-2078. PubMed ID: 31271486
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional activation of the cyclin A gene by the architectural transcription factor HMGA2.
Tessari MA; Gostissa M; Altamura S; Sgarra R; Rustighi A; Salvagno C; Caretti G; Imbriano C; Mantovani R; Del Sal G; Giancotti V; Manfioletti G
Mol Cell Biol; 2003 Dec; 23(24):9104-16. PubMed ID: 14645522
[TBL] [Abstract][Full Text] [Related]
12. Gene Expression Signature-Based Approach Identifies Antifungal Drug Ciclopirox As a Novel Inhibitor of HMGA2 in Colorectal Cancer.
Huang YM; Cheng CH; Pan SL; Yang PM; Lin DY; Lee KH
Biomolecules; 2019 Nov; 9(11):. PubMed ID: 31684108
[TBL] [Abstract][Full Text] [Related]
13. Molecular dissection of the architectural transcription factor HMGA2.
Noro B; Licheri B; Sgarra R; Rustighi A; Tessari MA; Chau KY; Ono SJ; Giancotti V; Manfioletti G
Biochemistry; 2003 Apr; 42(15):4569-77. PubMed ID: 12693954
[TBL] [Abstract][Full Text] [Related]
14. Derepression of HMGA2 via removal of ZBRK1/BRCA1/CtIP complex enhances mammary tumorigenesis.
Ahmed KM; Tsai CY; Lee WH
J Biol Chem; 2010 Feb; 285(7):4464-71. PubMed ID: 20007691
[TBL] [Abstract][Full Text] [Related]
15. PD173074, a selective FGFR inhibitor, reverses ABCB1-mediated drug resistance in cancer cells.
Patel A; Tiwari AK; Chufan EE; Sodani K; Anreddy N; Singh S; Ambudkar SV; Stephani R; Chen ZS
Cancer Chemother Pharmacol; 2013 Jul; 72(1):189-99. PubMed ID: 23673445
[TBL] [Abstract][Full Text] [Related]
16. The regulation of acetylation and stability of HMGA2 via the HBXIP-activated Akt-PCAF pathway in promotion of esophageal squamous cell carcinoma growth.
Wu Y; Wang X; Xu F; Zhang L; Wang T; Fu X; Jin T; Zhang W; Ye L
Nucleic Acids Res; 2020 May; 48(9):4858-4876. PubMed ID: 32313942
[TBL] [Abstract][Full Text] [Related]
17. Specific inhibitor of FGF receptor signaling: FGF-2-mediated effects on proliferation, differentiation, and MAPK activation are inhibited by PD173074 in oligodendrocyte-lineage cells.
Bansal R; Magge S; Winkler S
J Neurosci Res; 2003 Nov; 74(4):486-93. PubMed ID: 14598292
[TBL] [Abstract][Full Text] [Related]
18. HMGA2 inhibits apoptosis through interaction with ATR-CHK1 signaling complex in human cancer cells.
Natarajan S; Hombach-Klonisch S; Dröge P; Klonisch T
Neoplasia; 2013 Mar; 15(3):263-80. PubMed ID: 23479505
[TBL] [Abstract][Full Text] [Related]
19. HMGA2 expression in the PC-3 prostate cancer cell line is autonomous of growth factor stimulation.
Müller MH; Drieschner N; Focken T; Bartnitzke S; Winter N; Klemke M; Bullerdiek J
Anticancer Res; 2013 Aug; 33(8):3069-78. PubMed ID: 23898062
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional activation of FN1 and IL11 by HMGA2 promotes the malignant behavior of colorectal cancer.
Wu J; Wang Y; Xu X; Cao H; Sahengbieke S; Sheng H; Huang Q; Lai M
Carcinogenesis; 2016 May; 37(5):511-21. PubMed ID: 26964871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
